According to market observers, shares of the company are available at a premium of ₹18 in the grey market today ...

Ireland’s economic success is due in no small part to the life sciences sector, but the challenge now is how to maintain a ...

BofA Securities reports that the Life Sciences Tools sector struggled in fiscal year 2024. Spending by pharmaceutical and ...

Sai Life Sciences IPO price band is fixed at ₹522 to ₹549 per share. At the upper-end of the price band, the company plans to ...

The IPO received strong demand from qualified institutional buyers (QIBs). The current grey market premium (GMP) of the IPO ...

科罗拉多州威斯敏斯特市—TriSalus Life Sciences, Inc. (NASDAQ:TLSI)的董事Arjun JJ Desai最近出售了30,000股公司普通股。根据SEC文件报告，这笔交易发生于2024年12月10日，总价值约为110,700美元。

Sai Life Sciences Ltd.'s initial public offering entered its final day for subscription on Friday. It was subscribed 1.65 ...

Sai Life Sciences' Rs 3,042 crore IPO was oversubscribed 1.25 times on its second day, driven by institutional investors. The ...

Valuations of life sciences businesses declined in the wake of the global pandemic, but government stimulus and medical ...

北京时间2024年12月11日00时42分，Atai Life Sciences N.V.（ATAI.us）股票出现波动，股价大幅下跌5.03%。截至发稿，该股报1.51美元/股，成交量44.4207万股， 换手率 0.26%，振幅5.03%。

The Sai Life Sciences IPO is a combination of fresh issuance of Rs 950 crore worth of shares and an offer-for-sale of 3.81 ...

北京时间2024年12月05日02时41分，Atai Life Sciences N.V.（ATAI.us）股票出现波动，股价急速跳水5.52%。截至发稿，该股报1.54美元/股，成交量73.256万股， 换手率 0.44%，振幅9.51%。